Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BCPC
BCPC logo

BCPC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Balchem Corp (BCPC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
165.920
1 Day change
0.99%
52 Week Range
183.900
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Balchem Corp (BCPC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company's financial performance shows solid growth in revenue, net income, and EPS, the technical indicators and trading trends do not currently support a compelling entry point. Additionally, insider selling and the absence of significant positive catalysts make it prudent to hold off on buying this stock right now.

Technical Analysis

The MACD is below 0 and negatively contracting, indicating bearish momentum. The RSI is neutral at 21.924, and moving averages are converging, showing no clear trend. The stock is trading below the pivot level of 169.044, with key support at 162.999 and resistance at 175.089. Overall, the technical indicators suggest a lack of strong upward momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
4

Positive Catalysts

  • Hedge funds are significantly increasing their positions, with a 2062.50% increase in buying over the last quarter. The company's financials for Q4 2025 show strong YoY growth in revenue (9.84%), net income (16.80%), and EPS (18.63%).

Neutral/Negative Catalysts

  • Insiders are selling heavily, with a 1060.90% increase in selling over the last month. The gross margin has slightly decreased YoY by -0.97%. No recent news or significant event-driven catalysts. Stock trend analysis indicates a potential -10.78% decline in the next month.

Financial Performance

In Q4 2025, Balchem Corp reported revenue of $263.617 million (up 9.84% YoY), net income of $39.225 million (up 16.80% YoY), and EPS of 1.21 (up 18.63% YoY). However, gross margin dropped slightly to 35.62% (-0.97% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available.

Wall Street analysts forecast BCPC stock price to rise
Analyst Rating
0
Wall Street analysts forecast BCPC stock price to rise
Buy
Hold
Sell
0
Current: 164.290
sliders
Low
0
Averages
0
High
0
0
Current: 164.290
sliders
Low
0
Averages
0
High
0
Rothschild & Co Redburn
Neutral
initiated
$162
AI Analysis
2025-12-05
Reason
Rothschild & Co Redburn
Price Target
$162
AI Analysis
2025-12-05
initiated
Neutral
Reason
Rothschild & Co Redburn initiated coverage of Balchem with a Neutral rating and $162 price target. The company has a "resilient" business model built upon niche high-growth products, the analyst tells investors in a research note. However, the firm finds Balchem's valuation as "rich" at current share levels.
H.C. Wainwright
Buy
maintain
$189 -> $190
2025-10-22
Reason
H.C. Wainwright
Price Target
$189 -> $190
2025-10-22
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Balchem to $190 from $189 and keeps a Buy rating on the shares. The firm remains confident in Balchem's long-term prospects following the Q3 beat. The company's sales performance and operational efficiency are driving growth, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BCPC
Unlock Now

People Also Watch